After being diagnosed with a rare and deadly form of malignant melanoma - acral lentiginous melanoma - Dr George McGavin embarks on a highly emotional and deeply personal journey as he goes through treatment for his cancer. George’s treatment is targeted drug therapy, using drugs approved for use by the NHS only weeks before his diagnosis. During this journey, he is given unprecedented access to the process and science behind his medical treatment and diagnosis. He also meets some of the most highly regarded scientists in the field of cancer research in his quest to understand not just his disease but what the future holds as a whole for cancer treatment. Amongst them are Professor Sir Michael Stratton, director of the Wellcome Sanger Institute and chief executive officer of the Wellcome Genome Campus, whose work resulted in the discovery of the mutation in the B RAF gene responsible for his form of melanoma. George also travels to Houston, Texas to meet Professor James P Allison, winner of the 2018 Nobel Prize in Medicine, to find out about his pioneering work in the field of immunotherapy - the greatest breakthrough in cancer research in a century. Back home in his own hospital, he meets a unique group of stage four melanoma patients who owe their lives to Professor Allison’s work. Ultimately, his journey culminates when he receives his prognosis, after three months of treatment, which will determine his future. Will these groundbreaking drugs actually work?
We all know that mankind can't live without air, food and water...the same is true of salt. The salt on your table is a key to unlocking the story of our planet and the cosmos. Big History reveals how this simple molecule underpins our civilization
The possibility of medicine to replace damaged organs in the body is making important headway. This programme reports on efforts to replace the most inaccessible organs with spare parts - the cochlea of a profoundly deaf two year-old and damaged retinal cells with light sensitive electronic chips are two case studies featured in the programme.
The Ebola outbreak of 2014 almost brought the world to its knees, but this crisis has mobilized scientists and researchers, paving the way for new treatments and vaccines. From antibiotics and vaccines to computer programs that predict how viruses will spread, new lifesaving tools will be used to fight a wide range of viruses in the near future, including HIV, influenza, dengue fever, malaria, and a host of other killer diseases.
Channel 4 investigation looks into Coca Cola’s fight back on the incoming sugar tax, its close ties with influential scientists and some of the private lengths they are going to undermine a raft of public policy initiatives. The Coca Cola Company controls half the global soft drinks market; the one issue at the top of their agenda is a sugar tax.
This time, we meet a man who feels no pain, a woman who can smell Parkinson's disease, a man who can remember every face he has ever seen and a survivor of a head injury who woke up to find he could suddenly play the piano. These remarkable cases are shedding new light on one of the most mysterious parts of the human body - our brain.